Artixio

Pharmaceutical Regulatory & Compliance Services In USA

Pharmaceutical Consulting Services in USA

Pharmaceutical consulting company in the United States offering regulatory strategy, submissions, and compliance support for drug products.

End-to-End Regulatory Support
for Pharmaceutical Products in USA

Regulatory Affairs

Product Registration

IND (Investigational New Drug)

NDA (New Drug Application)

Technical Writing

Regulatory Strategy

Digital Marketing

Market Access

Regulatory Operations

Pharmaceutical Services for Global Regulatory Compliance

Artixio specializes in providing end-to-end regulatory support to the pharmaceutical industry. With a deep understanding of the complexities and ever-evolving regulations in global markets, we help pharmaceutical companies navigate the regulatory landscape efficiently. Our solutions help you navigate the complex landscape of global pharmaceutical regulations.
Our team of experts works closely with you to ensure that your products meet compliance with local and international standards at every stage, from development to post-market surveillance. Whether you’re entering a new market or maintaining compliance in existing ones, our services are designed to support your needs with precision and expertise.

We’re not the kind of pharma consulting services firm in USA that disappears after sending over a checklist. Once we’re involved, we stay hands-on—tracking progress, spotting issues early, and helping fix things when they go off track. A lot of the real work happens between submissions: following up with the FDA, clarifying feedback, double-checking documents. That’s where our team stays present, and that’s where we often make the biggest difference.

FAQS About Pharma Regulatory in USA

1. We’re planning to file with the FDA. Can you guide us through the process?

Yes. We can step in early—before anything is submitted—and help you figure out what’s required, what’s missing, and what needs to be in place. We also help with timelines, meeting prep, and responding to feedback from the FDA.

Yes, we do. Whether it’s a full IND or a supplement, we organize the content, check for gaps, and publish in eCTD format. We also help with submission through ESG and make sure everything’s validated properly.

Absolutely. We work with many non-U.S. clients. If you need a U.S. agent or support understanding what the FDA will expect from your data or documents, we can walk you through it.

Yes. If you’ve received feedback from the FDA and aren’t sure how to respond—or need help putting together the right documents—we can step in quickly and work with your team to prepare a clear and accurate response.

We support both. Some clients come to us after approval when they need help managing variations, safety updates, or labeling changes. Others reach out mid-process when they hit a roadblock.

Why Choose Artixio?

Expertise in 120+ countries

We respond quickly and don’t keep you waiting

You’ll always know what’s happening and what’s needed next.

We understand how the FDA works—and where issues often pop up.

No copy-paste strategies; we tailor everything to your product and situation.

Regulatory Expertise Across
Multiple Countries

India
Vietnam
Mexico​

United States

Brazil

European Union

Industries we serve

Pharmaceuticals

Cosmetics

Nutrition

Medtech

Biologics

Veterinary

Tips & Articles On Life Sciences

Orphan Drug Designation in South Korea (MFDS)

Orphan Drug Designation in

Orphan Drug Designation (ODD) is regulated by Ministry of Food and Drug Safety (MFDS)...

November 4, 2025
Prioritizing Genes from Publicly Available GWAS Summary Stats Using AI

Prioritizing Genes from Publicly

Artixio has developed an artificial intelligence based solution generating a list of prioritized genes...

October 13, 2025
CDSCO Simplifies Subsequent Importer Process for Medical Devices & IVDs

CDSCO Simplifies Subsequent Importer

India’s regulatory authority, the Central Drugs Standard Control Organization (CDSCO), has published an important...

October 3, 2025